Use the following year-end footnote disclosure from Pfizer's (10-mathrm{K}) report to answer parts (a) and (b). a.
Question:
Use the following year-end footnote disclosure from Pfizer's \(10-\mathrm{K}\) report to answer parts \(a\) and \(b\).
a. What amount does Pfizer report on its balance sheet as available-for-sale equity securities? Explain.
b. How does Pfizer report the net unrealized gain of \(\$ 114\) million ( \(\$ 127\) million - \(\$ 13\) million) in its financial statements?
Fantastic news! We've Found the answer you've been seeking!
Step by Step Answer:
Related Book For
Financial Accounting For MBAs
ISBN: 9781934319345
4th Edition
Authors: Peter D. Easton, John J. Wild, Robert F. Halsey, Mary Lea McAnally
Question Posted: